Weekly Fluconazole for the Prevention of Mucosal Candidiasis in Women with HIV Infection

1997121 citationsJournal Article

Authors

Paula Schuman · Wayne State University

Linnea Capps · Harlem Hospital Center

Grace Peng

Federico Vázquez · Wayne State University

Wafaa El-Sadr · Harlem Hospital Center

Anne I. Goldman · University of Minnesota

Beverly Alston

C. Lynn Besch ·

Abstract

Weekly fluconazole (200 mg) seems to be safe and effective in preventing oropharyngeal and vaginal candidiasis. This regimen has a useful role in the management of HIV-infected women who are at risk for recurrent mucosal candidiasis.

Topics & Keywords

Antifungal resistance and susceptibility Pneumocystis jirovecii pneumonia detection and treatment Fungal Infections and Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Annals of Internal Medicine

Volume 126, Issue 9, pp. 689-696

DOI: 10.7326/0003-4819-126-9-199705010-00003

Field-Weighted Citation Impact: 7.34